Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 850 of 1674 entries
View as:

North American Prodromal Synucleinopathy Consortium Stage 2

Phase: N/A Priority: Normal
NCT ID: NCT05826457 Org: User:
Start: 08/12/22 End: 05/01/25 Due: 05/01/26

Rivastigmine for Antimuscarinic Delirium

Phase: N/A Priority: Normal
NCT ID: NCT06382649 Org: User:
Start: 11/30/25 End: 07/31/26 Due: 07/31/27

Effects of Microplegia on Transfusion Rates After Cardiac Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05076604 Org: User:
Start: 03/25/19 End: 08/01/23 Due: 08/01/24

Bacterial Biofilms in Reconstructive Breast Prostheses Following Mastectomy

Phase: N/A Priority: Normal
NCT ID: NCT03213249 Org: User:
Start: 07/25/17 End: 09/26/18 Due: 09/26/19

Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01308944 Org: User:
Start: 08/31/10 End: 08/31/15 Due: 08/31/16

Using Social Norms to Encourage People to Exercise More

Phase: N/A Priority: Normal
NCT ID: NCT02907164 Org: User:
Start: 09/30/16 End: 01/31/17 Due: 01/31/18

Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02086604 Org: User:
Start: 09/18/14 End: 01/12/22 Due: 01/12/23

Rivastigmine to Prevent Recurrence of Antimuscarinic Delirium

Phase: N/A Priority: Normal
NCT ID: NCT06399679 Org: User:
Start: 11/04/24 End: 07/31/26 Due: 07/31/27

North American Prodromal Synucleinopathy Consortium

Phase: N/A Priority: Normal
NCT ID: NCT03623672 Org: User:
Start: 08/29/18 End: 07/31/26 Due: 07/31/27

Gated and Non-Gated Dynamic PET/CT Imaging

Phase: N/A Priority: Normal
NCT ID: NCT04283552 Org: User:
Start: 05/29/20 End: 04/10/23 Due: 04/10/24

Study of the Effects of Xenin-25 in Humans With and Without Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00798915 Org: User:
Start: 12/31/08 End: 12/31/12 Due: 12/31/13

Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00548418 Org: User:
Start: 02/28/07 End: 12/31/12 Due: 12/31/13

Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy

Phase: N/A Priority: Normal
NCT ID: NCT02723448 Org: User:
Start: 12/05/16 End: 07/23/20 Due: 07/23/21

Optimizing Decision Making About Breast Reconstruction After Mastectomy: A Patient-Centered Approach

Phase: N/A Priority: Normal
NCT ID: NCT03346161 Org: User:
Start: 01/09/18 End: 10/24/18 Due: 10/24/19

Pregabalin in CIPN

Phase: N/A Priority: Normal
NCT ID: NCT02394951 Org: User:
Start: 04/30/15 End: 04/02/18 Due: 04/02/19

Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma

Phase: N/A Priority: Normal
NCT ID: NCT04757662 Org: User:
Start: 05/14/21 End: 06/07/23 Due: 06/07/24

EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01000285 Org: User:
Start: 09/30/10 End: 04/30/16 Due: 04/30/17

Nutritional Therapy for Diabetic Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT01373814 Org: User:
Start: 09/03/10 End: 06/17/11 Due: 06/17/12

Lactoferrin and Lysozyme Supplementation for Environmental Enteric Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT02925026 Org: User:
Start: 10/31/16 End: 12/31/17 Due: 12/31/18

Dominantly Inherited Alzheimer Network (DIAN)

Phase: N/A Priority: Normal
NCT ID: NCT00869817 Org: User:
Start: 01/31/09 End: 07/31/25 Due: 07/31/26

Treatment of Chronic Stroke With IpsiHand

Phase: N/A Priority: Normal
NCT ID: NCT02552368 Org: User:
Start: 08/31/12 End: 11/30/15 Due: 11/30/16

CC-4047 (Pomalidomide) for Graft vs. Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT00770757 Org: User:
Start: 02/28/09 End: 10/31/11 Due: 10/31/12

Middle Meningeal Artery Embolization for Chronic Subdural Hematoma

Phase: N/A Priority: Normal
NCT ID: NCT04065113 Org: User:
Start: 09/19/19 End: 01/01/25 Due: 01/01/26

PET Detection of CCR2 in Human Atherosclerosis

Phase: N/A Priority: Normal
NCT ID: NCT04537403 Org: User:
Start: 10/01/20 End: 09/01/24 Due: 09/01/25

Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05427214 Org: User:
Start: 08/19/22 End: 10/17/24 Due: 10/17/25